Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4QA32
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 274 | 276 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.428 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.439 |
CLV_PCSK_FUR_1 | 288 | 292 | PF00082 | 0.330 |
CLV_PCSK_KEX2_1 | 274 | 276 | PF00082 | 0.278 |
CLV_PCSK_KEX2_1 | 290 | 292 | PF00082 | 0.292 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.440 |
CLV_PCSK_PC1ET2_1 | 290 | 292 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 313 | 317 | PF00082 | 0.364 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.546 |
DEG_SPOP_SBC_1 | 20 | 24 | PF00917 | 0.554 |
DOC_CYCLIN_RxL_1 | 310 | 318 | PF00134 | 0.600 |
DOC_CYCLIN_yCln2_LP_2 | 114 | 120 | PF00134 | 0.632 |
DOC_MAPK_gen_1 | 310 | 319 | PF00069 | 0.542 |
DOC_MAPK_gen_1 | 65 | 71 | PF00069 | 0.622 |
DOC_MAPK_MEF2A_6 | 116 | 123 | PF00069 | 0.643 |
DOC_MAPK_MEF2A_6 | 140 | 149 | PF00069 | 0.597 |
DOC_MAPK_MEF2A_6 | 310 | 319 | PF00069 | 0.560 |
DOC_MAPK_MEF2A_6 | 331 | 339 | PF00069 | 0.531 |
DOC_PP4_FxxP_1 | 102 | 105 | PF00568 | 0.691 |
LIG_14-3-3_CanoR_1 | 214 | 220 | PF00244 | 0.506 |
LIG_14-3-3_CanoR_1 | 274 | 278 | PF00244 | 0.486 |
LIG_Actin_WH2_2 | 96 | 112 | PF00022 | 0.692 |
LIG_ActinCP_TwfCPI_2 | 102 | 110 | PF01115 | 0.696 |
LIG_BRCT_BRCA1_1 | 40 | 44 | PF00533 | 0.500 |
LIG_eIF4E_1 | 80 | 86 | PF01652 | 0.635 |
LIG_EVH1_2 | 119 | 123 | PF00568 | 0.668 |
LIG_LIR_Gen_1 | 223 | 234 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 223 | 229 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 276 | 280 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 349 | 355 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.625 |
LIG_PCNA_yPIPBox_3 | 290 | 303 | PF02747 | 0.552 |
LIG_RPA_C_Fungi | 52 | 64 | PF08784 | 0.409 |
LIG_SH2_CRK | 280 | 284 | PF00017 | 0.328 |
LIG_SH2_GRB2like | 352 | 355 | PF00017 | 0.507 |
LIG_SH2_PTP2 | 39 | 42 | PF00017 | 0.361 |
LIG_SH2_SRC | 37 | 40 | PF00017 | 0.477 |
LIG_SH2_STAP1 | 226 | 230 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 252 | 255 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 37 | 40 | PF00017 | 0.349 |
LIG_SH3_2 | 105 | 110 | PF14604 | 0.524 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.507 |
LIG_SH3_3 | 114 | 120 | PF00018 | 0.461 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.443 |
LIG_SH3_3 | 78 | 84 | PF00018 | 0.504 |
LIG_SUMO_SIM_anti_2 | 127 | 133 | PF11976 | 0.476 |
LIG_SUMO_SIM_anti_2 | 31 | 37 | PF11976 | 0.361 |
LIG_SUMO_SIM_par_1 | 127 | 133 | PF11976 | 0.531 |
LIG_TYR_ITIM | 278 | 283 | PF00017 | 0.331 |
LIG_TYR_ITIM | 35 | 40 | PF00017 | 0.356 |
LIG_UBA3_1 | 283 | 290 | PF00899 | 0.390 |
LIG_UBA3_1 | 299 | 305 | PF00899 | 0.369 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.358 |
MOD_CK1_1 | 206 | 212 | PF00069 | 0.423 |
MOD_Cter_Amidation | 288 | 291 | PF01082 | 0.402 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.460 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.538 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.430 |
MOD_GSK3_1 | 339 | 346 | PF00069 | 0.276 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.398 |
MOD_N-GLC_2 | 338 | 340 | PF02516 | 0.335 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.391 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.440 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.610 |
MOD_NEK2_2 | 215 | 220 | PF00069 | 0.389 |
MOD_PIKK_1 | 147 | 153 | PF00454 | 0.464 |
MOD_PIKK_1 | 23 | 29 | PF00454 | 0.403 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.356 |
MOD_PKA_2 | 273 | 279 | PF00069 | 0.327 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.419 |
MOD_Plk_1 | 230 | 236 | PF00069 | 0.405 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.358 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.422 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.450 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.476 |
TRG_DiLeu_BaLyEn_6 | 81 | 86 | PF01217 | 0.548 |
TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 332 | 335 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.487 |
TRG_ER_diArg_1 | 1 | 4 | PF00400 | 0.424 |
TRG_ER_diArg_1 | 273 | 275 | PF00400 | 0.315 |
TRG_ER_diArg_1 | 47 | 50 | PF00400 | 0.559 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.547 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.543 |
TRG_NES_CRM1_1 | 127 | 142 | PF08389 | 0.544 |
TRG_Pf-PMV_PEXEL_1 | 242 | 247 | PF00026 | 0.300 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZB7 | Leptomonas seymouri | 82% | 100% |
A0A0S4JI71 | Bodo saltans | 65% | 75% |
A0A1X0P4P9 | Trypanosomatidae | 70% | 100% |
A0A3S7WYX0 | Leishmania donovani | 98% | 100% |
A4HEF5 | Leishmania braziliensis | 94% | 100% |
A4I1A4 | Leishmania infantum | 98% | 100% |
D0A5J6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
E9AXE0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
V5BN61 | Trypanosoma cruzi | 69% | 100% |